Soms Medical

In Locally Recurrent Breast Cancer (LRBC) and in Malignant Melanoma hyperthermia in combination with radiotherapy is included in leading guidelines:

Breast Cancer

• USA

  NCCN Clinical Practice Guidelines in Oncology, Breast Cancer Version 2.2017
  https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
  

• Germany

  Harms W, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Krug D, Piroth MD, Sautter-Bihl ML, Sedlmayer F, Souchon R, Wenz F, Sauer R:
  DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences.
  Strahlenther Onkol April 2016, Vol. 192, Issue 4, pp 199–208
  OPEN ACCESS https://link.springer.com/article/10.1007/s00066-015-0939-7
  
  AGO (Arbeitsgemeinschaft Gynäkologische Onkologie innerhalb der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und der Deutschen Krebsgesellschaft e.V. (DKG)
  Guidelines Breast, Version 2016.1D, Loko-regionäres Rezidiv
  OPEN ACCESS https://www.ago-online.de/.../2016D%2018_Loko-regionaeres_Rezidiv.pdf
  
  Leitlinienprogramm Onkologie der AWMF, Deutschen Krebsgesellschaft e.V. und Deutschen Krebshilfe e.V.
  Interdisziplinäre S3-Leitlinie für die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms; Langversion 4.0, Aktualisierung 2017, AWMF-Register-Nummer: 032-045OL.
  Strahlenther Onkol April 2016, Vol. 192, Issue 4, pp 199–208
  OPEN ACCESS http://www.leitlinienprogramm-onkologie.de/.../_Langversion_4.0.pdf
  

• Netherlands

  Richtlijn Borstkanker, Netherlands
  chapter "Locoregionaal recidief"
  OPEN ACCESS http://www.oncoline.nl/.../pagina.php&richtlijn_id=1069

Malignant Melanoma

• Europe

  Guideline on the Diagnosis and Treatment of Melanoma
  European Dermatology Forum
  Guideline-CM-09-2012-V8, Update 2012
  OPEN ACESS http://www.euroderm.org/edf/index.php/edf-guidelines/category/5-guidelines-miscellaneous
  

• Germany

  S3-Leitlinie zur Diagnostik,Therapie und Nachsorge des Melanoms
  Version 2.0-Juli2016, AWMF-Register-Nummer: 032/024OL
  Kapitel 3.4.7 Radiotherapie bei lokoregionalen Metastasen
  3.5.7. Radiotherapie von Fernmetastasen
  OPEN ACCESS http://www.awmf.org/uploads/tx_szleitlinien/032-024OLl_S3_Melanom_2016-08.pdf

ESHO Guidelines

ESHO GuidelinesIn 2017, the European Society of Hyperthermic Oncology has issued quality assurance guidelines:


• Trefná HD, Crezee H, Schmidt M, Marder D, Lamprecht U, Ehmann M, Hartmann J, Nadobny J, Gellermann J, van Holthe N, Ghadjar P, Lomax N, Abdel-Rahman S, Bert C, Bakker A, Hurwitz MD, Diederich CJ, Stauffer PR, van Rhoon GC
  Quality assurance guidelines for superficial hyperthermia clinical trials:
  I. Clinical requirements
  Int J Hyperthermia. 2017 Jan 31:1-12
  https://www.ncbi.nlm.nih.gov/pubmed/28049386
  
• Dobšíček Trefná H, Crezee J, Schmidt M, Marder D, Lamprecht U, Ehmann M, Nadobny J, Hartmann J, Lomax N, Abdel-Rahman S, Curto S, Bakker A, Hurwitz MD, Diederich CJ, Stauffer PR, Van Rhoon GC
  Quality assurance guidelines for superficial hyperthermia clinical trials:
  II. Technical requirements for heating devices
  Strahlenther Onkol. 2017 May;193(5):351-366
  OPEN ACCESS https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405104/
  
  
Water-filtered infrared A is listed as an appropriate and accepted technique. The TWH1500 device is compliant with these requirements.